Related references
Note: Only part of the references are listed.Therapeutic effects of losartan on prostatic hyperplasia in spontaneously hypertensive rats
Shogo Shimizu et al.
LIFE SCIENCES (2021)
Oxidative stress in cardiac hypertrophy: From molecular mechanisms to novel therapeutic targets
Chrishan J. A. Ramachandra et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
The Impact of Ang-(1-9) and Ang-(3-7) on the Biological Properties of Prostate Cancer Cells by Modulation of Inflammatory and Steroidogenesis Pathway Genes
Kamila Dominska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Theo Vos et al.
LANCET (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China
X. Liu et al.
PUBLIC HEALTH (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Periprostatic Adipose Tissue Favors Prostate Cancer Cell Invasion in an Obesity-Dependent Manner: Role of Oxidative Stress
Victor Laurent et al.
MOLECULAR CANCER RESEARCH (2019)
Midlife metabolic factors and prostate cancer risk in later life
Barbra A. Dickerman et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Eryptosis and oxidative damage in hypertensive and dyslipidemic patients
Carmen Elisa Pinzon-Diaz et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation
Guo-zheng Liang et al.
ACTA PHARMACOLOGICA SINICA (2018)
Nox4 genetic inhibition in experimental hypertension and metabolic syndrome
Ghina Bouabout et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2018)
Antihypertensive drugs use and the risk of prostate cancer: a meta-analysis of 21 observational studies
Liang Cao et al.
BMC UROLOGY (2018)
Identification of essential hypertension biomarkers in human urine by non-targeted metabolomics based on UPLC-Q-TOF/MS
Huan Zhao et al.
CLINICA CHIMICA ACTA (2018)
Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients
Xian-Tao Zeng et al.
FRONTIERS IN PHYSIOLOGY (2018)
A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis
Yasuyoshi Miyata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Impact of Oxidative Stress on the Heart and Vasculature Part 2 of a 3-Part Series
Thomas Muenzel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases
Xiao C. Li et al.
PHARMACOLOGICAL RESEARCH (2017)
ROS Signaling by NADPH Oxidase 5 Modulates the Proliferation and Survival of Prostate Carcinoma Cells
Monika Hoell et al.
MOLECULAR CARCINOGENESIS (2016)
Oxidative stress in prostate hyperplasia and carcinogenesis
Udensi K. Udensi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction
Alexander Sirker et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Is angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy protective against prostate cancer?
Yeqing Mao et al.
ONCOTARGET (2016)
Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity
Gagan Deep et al.
SCIENTIFIC REPORTS (2016)
NOX4 NADPH Oxidase-Dependent Mitochondrial Oxidative Stress in Aging-Associated Cardiovascular Disease
Aleksandr E. Vendrov et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
NADPH oxidases and cancer
Krishnendu Roy et al.
CLINICAL SCIENCE (2015)
Oxidative stress: a concept in redox biology and medicine
Helmut Sies
REDOX BIOLOGY (2015)
Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review
Paola Lucia Minciullo et al.
UROLOGIA INTERNATIONALIS (2015)
Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume
Eu Chang Hwang et al.
LUTS-LOWER URINARY TRACT SYMPTOMS (2015)
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
Alugoju Phaniendra et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2015)
The Basic Biology of Redoxosomes in Cytokine-Mediated Signal Transduction and Implications for Disease-Specific Therapies
Netanya Y. Spencer et al.
BIOCHEMISTRY (2014)
Nox family NADPH oxidases: Molecular mechanisms of activation
Ralf P. Brandes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
The signaling pathway of NADPH oxidase and its role in glomerular diseases
Song Mao et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2014)
NADPH oxidase subunit p22Phox-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer
Qi Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: Posthoc analyses of a lower urinary tract symptoms population
Hideaki Ito et al.
NEUROUROLOGY AND URODYNAMICS (2013)
Is there an association between coronary atherosclerosis and carcinoma of the prostate in men aged 50 years and older An autopsy and coroner based post-mortem study
B. I. Omalu et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE (2013)
NOX5 Expression Is Increased in Intramyocardial Blood Vessels and Cardiomyocytes after Acute Myocardial Infarction in Humans
Nynke E. Hahn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Prostate Cancer Risk in Men with Baseline History of Coronary Artery Disease: Results from the REDUCE Study
Jean-Alfred Thomas et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
The role of oxidative stress in prostate cancer
Gaytri Gupta-Elera et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Correlations Among Cardiovascular Risk Factors, Prostate Blood Flow, and Prostate Volume in Patients With Clinical Benign Prostatic Hyperplasia
I-Hung Chen et al.
UROLOGY (2012)
Aiding and abetting roles of NOX oxidases in cellular transformation
Karen Block et al.
NATURE REVIEWS CANCER (2012)
High Glucose Concentration Affects the Oxidant-Antioxidant Balance in Cultured Mouse Podocytes
Agnieszka Piwkowska et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
ROS Signaling by NOX4 Drives Fibroblast-to-Myofibroblast Differentiation in the Diseased Prostatic Stroma
Natalie Sampson et al.
MOLECULAR ENDOCRINOLOGY (2011)
Advances in metal-induced oxidative stress and human disease
Klaudia Jomova et al.
TOXICOLOGY (2011)
Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE(-/-) mice
Courtney P. Judkins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Serum Oxidized Protein and Prostate Cancer Risk within the Prostate Cancer Prevention Trial
Ashraful Hoque et al.
CANCER PREVENTION RESEARCH (2010)
Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 (Nox5) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium/Calmodulin-Dependent, Rac-1-Independent Pathways in Human Endothelial Cells
Augusto C. Montezano et al.
CIRCULATION RESEARCH (2010)
Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer
Gianna Pace et al.
UROLOGIA INTERNATIONALIS (2010)
Hypertensive Status and Lipoprotein Oxidation in an Elderly Population at High Cardiovascular Risk
Monica Guxens et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Identification of Structural Elements in Nox1 and Nox4 Controlling Localization and Activity
Ina Helmcke et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Oxidative stress in prostate cancer
Lakshmipathi Khandrika et al.
CANCER LETTERS (2009)
Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer
Zorica Arsova-Sarafinovska et al.
CLINICAL BIOCHEMISTRY (2009)
Subcellular localization of Nox4 and regulation in diabetes
Karen Block et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype
Binod Kumar et al.
CANCER RESEARCH (2008)
NADPH Oxidases, Reactive Oxygen Species, and Hypertension Clinical implications and therapeutic possibilities
Tamara M. Paravicini et al.
DIABETES CARE (2008)
Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production
Sergey I. Dikalov et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Angiotensin II induces oxidative stress in prostate cancer
Hiroji Uemura et al.
MOLECULAR CANCER RESEARCH (2008)
A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis
K. Goswami et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
ROS as signalling molecules:: mechanisms that generate specificity in ROS homeostasis
Benoit D'Autreaux et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Regulation of Nox and Duox enzymatic activity and expression
J. David Lambeth et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Associations between coronary heart disease, obesity and histological prostate cancer
Konstantinos N. Stamatiou et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
DNA damage levels in prostate cancer cases and controls
Kristin L. Lockett et al.
CARCINOGENESIS (2006)
Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
H Ozmen et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia
A Aydin et al.
CLINICAL BIOCHEMISTRY (2006)
Altered metabolism and mitochondrial genome in prostate cancer
GD Dakubo et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Nox1 is involved in angiotensin II-mediated hypertension - A study in Nox1-deficient mice
K Matsuno et al.
CIRCULATION (2005)
FREE RADICAL INJURY AND ANTIOXIDANT STATUS IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA AND PROSTATE CANCER
D. S. L. Srivastava et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2005)
Increased noxl and hydrogen peroxide in prostate cancer
SD Lim et al.
PROSTATE (2005)
Antioxidant system activation in prostate cancer
MI Yilmaz et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2004)
Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated
K Camphausen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Angiotensin converting enzyme inhibitors for cancer treatment?
H Lindberg et al.
ACTA ONCOLOGICA (2004)
Association of hypertension with symptoms of benign prostatic hyperplasia
MC Michel et al.
JOURNAL OF UROLOGY (2004)
Association between captopril, other antihypertensive drugs and risk of prostate cancer
G Ronquist et al.
PROSTATE (2004)
Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo - Effect on endothelial NAD(P)H oxidase system
M Higashi et al.
CIRCULATION RESEARCH (2003)
NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells
SS Brar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Malondialdehyde in benign prostate hypertrophy: a useful marker?
RA Merendino et al.
MEDIATORS OF INFLAMMATION (2003)
Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction
PAJ Krijnen et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Mitogen-activated protein kinase pathways in redox signaling
M Torres
FRONTIERS IN BIOSCIENCE (2003)
Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia
K Sugaya et al.
INTERNATIONAL JOURNAL OF UROLOGY (2003)
Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II
U Landmesser et al.
HYPERTENSION (2002)
Evidence for activation of the renin-angiotensin system in the human prostate:: increased angiotensin II and reduced AT1 receptor expression in prostatic hyperplasia
DT Dinh et al.
JOURNAL OF PATHOLOGY (2002)
The AT1-type angiotensin receptor in oxidative stress and atherogenesis part I:: Oxidative stress and atherogenesis
G Nickenig et al.
CIRCULATION (2002)
Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia
L Nassis et al.
JOURNAL OF PATHOLOGY (2001)
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia
ME Fabiani et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice
HD Wang et al.
CIRCULATION RESEARCH (2001)
Indices of lipid peroxidation in vivo: Strengths and limitations
EA Meagher et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Relationship between benign prostatic hyperplasia and history of coronary artery disease in elderly men
KM Weisman et al.
PHARMACOTHERAPY (2000)
Share Paper
